FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3466411000001109: Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25664701000001117 Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
59519901000001112 Velosef 250mg/5ml syrup (Bristol-Myers Squibb Pharmaceuticals Ltd) 100 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Is a Cefradine 250mg/5ml oral solution 100 ml true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Is pack of Velosef 250mg/5ml syrup (IXL Pharma Ltd) false Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has active ingredient Cefradine false Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has manufactured dose form Conventional release oral syrup false Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has AMP Velosef 250mg/5ml syrup (IXL Pharma Ltd) true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has specific active ingredient Cefradine true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Velosef 250mg/5ml syrup (IXL Pharma Ltd) 100 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start